Novanta (FRA:1GSN) Cyclically Adjusted Revenue per Share: €19.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1GSN Novanta Inc FRA:1GSN
88 GF Score
Price €126.00
GF Value €137.58
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Novanta Cyclically Adjusted Revenue per Share?

Novanta FRA:1GSN -2.33% 88 Cyclically Adjusted Revenue per Share is €19.92 as of Mar. 2026. GuruFocus rates FRA:1GSN with a GF Score™ of 88/100 and a GF Value™ of €137.58 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Novanta's adjusted revenue per share for the three months ended in Mar. 2026 was €5.416. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €19.92 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Novanta's average Cyclically Adjusted Revenue Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Novanta was 13.40% per year. The lowest was -8.00% per year. And the median was -3.00% per year.

As of today (2026-07-22), Novanta's current stock price is €126.00. Novanta's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €19.92. Novanta's Cyclically Adjusted PS Ratio of today is 6.33.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novanta was 12.47. The lowest was 1.05. And the median was 6.78.


Novanta  (FRA:1GSN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Novanta's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=126.00/19.92
=6.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novanta was 12.47. The lowest was 1.05. And the median was 6.78.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Novanta Cyclically Adjusted Revenue per Share Related Terms


Novanta Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Novanta's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novanta Cyclically Adjusted Revenue per Share Chart

Novanta Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.16 16.64 17.82 20.36 20.06

Novanta Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.21 19.11 19.26 20.06 19.92

FRA:1GSN vs ST, VNT, BMI: Cyclically Adjusted Revenue per Share Comparison

For the Scientific & Technical Instruments subindustry, Novanta's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novanta Cyclically Adjusted PS Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Novanta's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Novanta's Cyclically Adjusted PS Ratio falls into.


FRA:1GSN
88GF Score
Novanta Inc FRA:1GSN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novanta Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novanta's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.416/330.2130*330.2130
=5.416

Current CPI (Mar. 2026) = 330.2130.

Novanta Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.493 241.018 3.416
201609 2.496 241.428 3.414
201612 2.679 241.432 3.664
201703 2.901 243.801 3.929
201706 2.989 244.955 4.029
201709 3.524 246.819 4.715
201712 3.505 246.524 4.695
201803 3.364 249.554 4.451
201806 3.629 251.989 4.756
201809 3.883 252.439 5.079
201812 3.869 251.233 5.085
201903 3.921 254.202 5.093
201906 3.867 256.143 4.985
201909 3.931 256.759 5.056
201912 4.036 256.974 5.186
202003 3.957 258.115 5.062
202006 3.612 257.797 4.627
202009 3.400 260.280 4.314
202012 3.388 260.474 4.295
202103 3.816 264.877 4.757
202106 3.888 271.696 4.725
202109 4.224 274.310 5.085
202112 4.917 278.802 5.824
202203 5.182 287.504 5.952
202206 5.670 296.311 6.319
202209 6.268 296.808 6.973
202212 5.727 296.797 6.372
202303 5.685 301.836 6.219
202306 5.878 305.109 6.362
202309 5.759 307.789 6.179
202312 5.381 306.746 5.793
202403 5.880 312.332 6.217
202406 6.071 314.175 6.381
202409 6.095 315.301 6.383
202412 6.289 315.605 6.580
202503 5.975 319.799 6.170
202506 5.793 322.561 5.930
202509 5.859 324.800 5.957
202512 5.721 324.054 5.830
202603 5.416 330.213 5.416

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €19.92 mean?
Novanta (FRA:1GSN) has a Cyclically Adjusted Revenue per Share of €19.92 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Novanta and its competitors.
Is Novanta's Cyclically Adjusted Revenue per Share too high?
Novanta's current Cyclically Adjusted Revenue per Share is €19.92. Overall, Novanta has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novanta's Cyclically Adjusted Revenue per Share compare to ST and VNT?
Novanta's Cyclically Adjusted Revenue per Share of €19.92 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Hardware company?
A good Cyclically Adjusted Revenue per Share depends on the Hardware industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Novanta and its competitors. Novanta's current Cyclically Adjusted Revenue per Share is €19.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novanta stock overvalued right now?
Based on GuruFocus' analysis, Novanta (FRA:1GSN) is currently considered Fairly Valued. The stock's GF Value™ is €137.58, compared to a current price of €126.00 — trading 8.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €19.92. Novanta's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Novanta (FRA:1GSN), the current Cyclically Adjusted Revenue per Share is €19.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novanta (FRA:1GSN) Overvalued in 2026?

Based on GuruFocus' analysis, Novanta stock appears to be undervalued. The current stock price of €126.00 is trading 8.4% below its estimated GF Value™ of €137.58. GuruFocus considers Novanta to be Fairly Valued.

Key valuation signals for FRA:1GSN:

  • Cyclically Adjusted Revenue per Share: €19.92
  • GF Value™: €137.58 vs. price of €126.00 (8.4% below fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the FRA:1GSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novanta Business Description

Address 125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
88GF Score

Get the complete analysis for FRA:1GSN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€126.00
Price
€137.58
GF Value